The World Health Organisation (WHO) has granted approval for Emergency Use Listing (EUL) to India’s indigenously made COVID-19 vaccine, Covaxin.
- Covaxin has been developed and manufactured by Hyderabad based firm Bharat Biotech.
- The Technical Advisory Group of WHO, on November 3, 2011, has recommended the Emergency Use Listing status for Covaxin.
- Covaxin is one of the six vaccines that have received emergency use authorisation from Drugs Controller General of India and is being used in the nationwide inoculation programme, along with Covishield and Sputnik V.
- Bharat Biotech Chairman and Managing Director Dr. Krishna Ella said, the validation by WHO is a very significant step towards ensuring global access to India’s widely administered, safe, and efficacious Covaxin. He was speaking in Hyderabad after Covaxin received nod from the WHO.
